2031 - 2040 of 6456 Results
Title
Year
-
OPENTitle: Clinical Comparison of 99mTc Exametazime and 123I Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain InjuryJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 1Start Page: e87009End Page: e87009Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0087009Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0087009&type=printableCitation Count: 16
-
OPENTitle: Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’sJournal Name: Journal of Patient-Reported OutcomesPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 40End Page: 40Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s41687-023-00577-9Best OA location URL: https://jpro.springeropen.com/counter/pdf/10.1186/s41687-023-00577-9Citation Count: 21
-
OPENTitle: Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severityJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page: 7End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-015-0185-3Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-015-0185-3Citation Count: 93
-
OPENTitle: Overlap between Parkinson disease and Alzheimer disease in ABCA7 functional variantsJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 2Issue #: 1Start Page: e44End Page: e44Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000000044Best OA location URL: https://ng.neurology.org/content/nng/2/1/e44.full.pdfCitation Count: 40
- Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion2020OPENTitle: Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusionJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 7Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000000711Best OA location URL: https://nn.neurology.org/content/nnn/7/3/e711.full.pdfCitation Count: 12
-
OPENTitle: Converging mediators from immune and trophic pathways to identify Parkinson disease dementiaJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 3Issue #: 1Start Page: e193End Page: e193Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000000193Best OA location URL: https://nn.neurology.org/content/nnn/3/1/e193.full.pdfCitation Count: 17
-
OPENTitle: Course of psychiatric symptoms and global cognition in early Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 83Issue #: 12Start Page: 1096End Page: 1103Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000000801Best OA location URL: https://n.neurology.org/content/neurology/83/12/1096.full.pdfCitation Count: 121
-
OPENTitle: Regional neuropathology distribution and verbal fluency impairments in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 65Issue #:Start Page: 73End Page: 78Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.014Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6774852Citation Count: 26
- L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression2019OPENTitle: L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progressionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 65Issue #:Start Page: 55End Page: 61Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.022Best OA location URL: https://www.repository.cam.ac.uk/handle/1810/294951Citation Count: 35
-
OPENTitle: Parkinson's disease motor subtype changes during 20 years of follow-upJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 76Issue #:Start Page: 104End Page: 107Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.024Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6980332Citation Count: 33